glp 1 and leptin Leptin, Nesfatin-1, Glucagon-like Peptide 1, Short-Chain Fatty Acids in Colon Cancer and Inflammatory Bowel Disease Frontiers | The role of

According to the Semaglutide Treatment Effect in People with Obesity (STEP) program studies, people with overweight or obesity (without T2DM) who received semaglutide 2.4 mg and underwent lifestyle interventions experienced an average weight reduction of 14.7- 17.4% [116]

This may impact the body's sleep-wake cycle (otherwise known as circadian rhythm), which can affect sleep

Including genetic predisposition data in insurance appeals can strengthen the narrative: 'Patient carries multiple variants associated with impaired satiety signaling and metabolic dysregulation despite documented lifestyle efforts.' This shifts the framing from personal responsibility to biology, potentially improving authorization rates

Prioritize compound movements

Semaglutide and liraglutide are among the most effective, with semaglutide often leading to greater weight loss